SFM
GOSS icon

Sphera Funds Management’s Gossamer Bio GOSS Stock Holding History

Sphera Funds Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-222,134
Closed -$200K – 125
2024
Q2 		$200K Sell
222,134
-805,000
-78% -$602K 0.03% 116
2024
Q1 		$1.21M Sell
1,027,134
-310,956
-23% -$342K 0.17% 94
2023
Q4 		$1.22M Sell
1,338,090
-594,478
-31% -$439K 0.2% 82
2023
Q3 		$1.61M Buy
+1,932,568
New +$2.23M 0.29% 68

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sphera Funds Management's GOSS Position: Q3 2024 in Review

Sphera Funds Management sold out of Gossamer Bio (GOSS) in Q3 2024, closing a stake of 222,134 shares — an estimated $200K sold.

Sphera Funds Management first reported a position in GOSS in Q3 2023 and held it in 4 quarters. The position peaked at $1.61M in Q3 2023. 100 funds tracked by Wall St. Rank hold GOSS as of Q3 2024.

  • Sphera Funds Management reported no remaining Gossamer Bio position as of Q3 2024 after selling out during the quarter.
  • Sphera Funds Management sold 222,134 Gossamer Bio shares in Q3 2024, an estimated $200K.
  • Sphera Funds Management first reported a position in Gossamer Bio in Q3 2023 and held it in 4 quarters.
  • Sphera Funds Management's Gossamer Bio position peaked at $1.61M in Q3 2023.
  • 100 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2024.

Based on Sphera Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.